Trial Profile
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2014
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Hypertension
- Focus Therapeutic Use
- 27 Mar 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 09 Feb 2013 New source identified and integrated (Mayo Clinic: 11-007035).
- 29 May 2012 New trial record